Author:
Hassan Said A.,Nashat Nancy W.,Elghobashy Mohamed R.,Abbas Samah S.,Moustafa Azza A.
Subject
Spectroscopy,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference42 articles.
1. Drug impurity profiling strategies;Görög;Talanta,1997
2. Impurity profile: significance in active pharmaceutical ingredient;Bari;Eurasian journal of analytical chemistry,2007
3. FDA, FDA requests removal of all ranitidine products (zantac) from the market.
4. FDA, NDAs Impurities in Drug Substances, (2000).
5. ICH, Impurities in new drug substances Q3A (R2), (2006).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献